3 withdrawn, 1 terminated. 3 Phase 1, 3 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
| Phase 2 | 3 | Withdrawn 3 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Dermatophagoides Farinae: new trials by email Literature Review of Dermatophagoides Farinae trials Research Report on Dermatophagoides Farinae
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation Anakinra, Anakinra Matching Placebo, Dermatophagoides Farinae - Asthma | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2020-09-01 | 2021-05-14 | |
| Anakinra as a Rescue Treatment for Allergic Inflammation Anakinra, Preservative-free 0.9% sodium chloride (Placebo), House dust mite allergen - Asthma, Allergic | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-12-16 | 2022-06-08 | |
| Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation Anakinra, Anakinra Matching Placebo, Dermatophagoides Farinae - Asthma | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-08-09 | 2021-05-07 | |
| Screening Inhaled Allergen Challenge for Dermatophagoides Farinae Der f - Asthma | Early Phase 1 | Terminated | University of North Carolina, Chapel Hill | 14 | 2018-01-29 | 2022-10-18 |
Asthma (4)
University of North Carolina, Chapel Hill (4)
United States (1)
Michelle Hernandez, MD (3) · Michelle Hernandez (1)
R01HL135235 (4)